Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Fluxion Biosciences, which provides cellular analysis tools for use in life science research and drug discovery applications, has signed an exclusive distribution agreement with switzerland-based Bucher Biotec.
Subscribe to our email newsletter
Bucher will handle sales and service in Switzerland of Fluxion’s BioFlux research tools for live cell image analysis in drug discovery.
The Fluxion BioFlux 200 system is ideal for live cell imaging in applications such as cell adhesion and microbial biofilm studies. BioFlux 200 incorporates Fluxion’s proprietary microfluidic design to deliver an automated, reproducible system for studying live cells and biofilms under controlled-shear conditions.
The system simulates in vivo physiological conditions more closely and at higher throughput than other approaches.
Roland Bucher, CEO of Bucher, said: “The cutting-edge BioFlux systems for live cell imaging will be of interest to our current customers and will help us attract new ones. Our sales, scientific support and service team bring the highest pre- and post-sales customer support to the Fluxion products and its applications.”